Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP399804.RAnpvlcWizXukYwWLcx1uJg4Sj4vN6PX2du2mzFt7G7Qg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP399804.RAnpvlcWizXukYwWLcx1uJg4Sj4vN6PX2du2mzFt7G7Qg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP399804.RAnpvlcWizXukYwWLcx1uJg4Sj4vN6PX2du2mzFt7G7Qg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP399804.RAnpvlcWizXukYwWLcx1uJg4Sj4vN6PX2du2mzFt7G7Qg130_provenance.
- NP399804.RAnpvlcWizXukYwWLcx1uJg4Sj4vN6PX2du2mzFt7G7Qg130_assertion description "[In this study, we showed that recombinant human prothrombin kringle-1, -2. and -1-2 (rk-1, -2, -1-2) all have potent anti-angiogenic activities, which inhibit Lewis lung carcinoma (LLC) tumor growth and metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP399804.RAnpvlcWizXukYwWLcx1uJg4Sj4vN6PX2du2mzFt7G7Qg130_provenance.
- NP399804.RAnpvlcWizXukYwWLcx1uJg4Sj4vN6PX2du2mzFt7G7Qg130_assertion evidence source_evidence_literature NP399804.RAnpvlcWizXukYwWLcx1uJg4Sj4vN6PX2du2mzFt7G7Qg130_provenance.
- NP399804.RAnpvlcWizXukYwWLcx1uJg4Sj4vN6PX2du2mzFt7G7Qg130_assertion SIO_000772 12831060 NP399804.RAnpvlcWizXukYwWLcx1uJg4Sj4vN6PX2du2mzFt7G7Qg130_provenance.
- NP399804.RAnpvlcWizXukYwWLcx1uJg4Sj4vN6PX2du2mzFt7G7Qg130_assertion wasDerivedFrom befree-2016 NP399804.RAnpvlcWizXukYwWLcx1uJg4Sj4vN6PX2du2mzFt7G7Qg130_provenance.
- NP399804.RAnpvlcWizXukYwWLcx1uJg4Sj4vN6PX2du2mzFt7G7Qg130_assertion wasGeneratedBy ECO_0000203 NP399804.RAnpvlcWizXukYwWLcx1uJg4Sj4vN6PX2du2mzFt7G7Qg130_provenance.
- befree-2016 importedOn "2016-02-19" NP399804.RAnpvlcWizXukYwWLcx1uJg4Sj4vN6PX2du2mzFt7G7Qg130_provenance.